Online ISSN: 1949-2553
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

Epigenetic Signatures Differentiate Leiomyosarcoma Subtypes

Oncotarget

August 4, 2021
In the cover paper chosen for Oncotarget’s Volume 12, Issue 16, researchers from Yale University made headway in stratifying subtypes of a rare and aggressive form of cancer: leiomyosarcoma (LMS). continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #16

Oncotarget

August 3, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 16. continue reading »

Biomarker Predicts Treatment Efficacy in Triple-Negative Breast Cancer

Oncotarget

July 27, 2021
In this 2020 paper, researchers searched for biomarkers of sacituzumab govitecan treatment efficacy in triple-negative breast cancer. continue reading »

Metal Compounds Induce DNA Instability In Cancer Cells

Oncotarget

July 21, 2021
Researchers assayed the chromosome-disrupting capabilities of six terpyridine platinum compounds in cancer cells. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #15

Oncotarget

July 20, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 15. continue reading »